The current price is in 3,71$, In this post we are going to talk about the listed company Fate Therapeutics Inc, its leaders are Bahram Valamehr (Chief Research & Development Officer), Edward J. Dulac (Chief Financial Officer & Accounting Officer), J. Scott Wolchko (President, Chief Executive Officer & Director), Mark Plavsic (Chief Technical Officer), Wen Bo Wang (Senior Vice President-Technical Operations), Yu Waye Chu (Senior Vice President-Clinical Development), they lead it to work in Biotechnology: Biological Products (No Diagnostic Substances) especially in the North America region.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 3,71$ moving between 3,59$ and 3,83$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
